Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Industry Supported Education
Get valuable insight on select drug products and medically-relevant topics, courtesy of the pharmaceutical industry.
A new study suggests that many patients with COPD may be undertreated (particularly with long-acting maintenance medications), despite recommended treatment guidelines.
Young children are at increased risk of becoming seriously ill with pneumonia - but unlike in years past, the cause is usually a respiratory virus.
Meda announced that the Food and Drug Administration (FDA) has approved Dymista (azelastine HCl and fluticasone propionate) for the relief of symptoms of seasonal allergic rhinitis (SAR) in patients ages 6-11 who require treatment with both components.
The Food and Drug Administration (FDA) has accepted for Priority Review a supplemental New Drug Application (sNDA) for Rapamune (sirolimus; Pfizer) for the treatment of lymphangioleiomyomatosis (LAM).
Featured courses from mycme
In this activity, experts will review the role of inflammation in both the large and ...
This program defines and distinguishes asthma from COPD, discusses the impact of these conditions on ...
- Recall of Two IV Antibiotics Announced
- Five Things ID Experts Want You to Know Before You Prescribe an Antibiotic
- What's Changed in Immunization Recommendations From CDC Advisory Committee
- Peanut Allergy Patch Shows Promise in Latest Study
- IUD Approval Gives Women New Long-Acting Birth Control Option